Rochester Drug Co-Operative v. Braintree Laboratories

MEMORANDUM OPINION

ROBINSON, District Judge.

I. INTRODUCTION

This is an antitrust action arising out of a patent infringement case filed on May 16, 2003 by Braintree Laboratories, Inc. (“Braintree” or “defendant”), a pharmaceutical company selling the constipation drug polyethylene glycol 3350 (“PEG”) in the United States under the brand name MiraLax®, against a generic drug manufacturer, Schwarz Pharma, Inc. (“Schwarz”), seeking to preclude FDA approval for Schwarz’s generic PEG drug GlycoLax ®. (Civ. No. 03-477-SLR (hereinafter, “the Braintree/Schwarz litigation”)) The Braintree/Schwarz…